By IDSE News Staff
The FDA approved a live, nonreplicating smallpox–monkeypox combination vaccine (MVA-BN; Jynneos, Bavarian Nordic A/S) to prevent smallpox and monkeypox in adults aged 18 years and older determined to be at high risk for either infection.
This is the only currently FDA-approved vaccine for the prevention of monkeypox disease.